Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17 beta-hydroxysteroid dehydrogenase activity, and serum hormone concentrations.
D015067:17-Hydroxysteroid Dehydrogenases / Q000378:metabolism; D000328:Adult; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D004359:Drug Therapy, Combination; D004717:Endometrium / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D006728:Hormones / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged; D011960:Receptors, Estrogen / Q000187:drug effects; D011980:Receptors, Progesterone / Q000187:drug effects; D013629:Tamoxifen / Q000494:pharmacology*
D006728:Hormones; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen; D017258:Medroxyprogesterone Acetate; D015067:17-Hydroxysteroid Dehydrogenases; D008525:Medroxyprogesterone